Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast (WALNUT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Centre for Ocular Research & Education
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages between 6 and 12 years
- Myopia between -1.00 and -4.00 D
Exclusion Criteria:
- Participating in any clinical or other research study
- Contact lens wearer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DEVICE_FEASIBILITY
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Lens Design 1
Spectacle lenses design 1, fitted into spectacle frames
|
Spectacle lenses with clear central apertures
|
|
EXPERIMENTAL: Lens Design 2
Spectacle lenses design 2, fitted into spectacle frames
|
Spectacle lenses with clear central apertures
|
|
EXPERIMENTAL: Lens Design 3
Spectacle lenses design 3, fitted into spectacle frames
|
Spectacle lenses with clear central apertures
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance Visual Acuity
Time Frame: 2 weeks
|
Measurement of best corrected distance visual acuity
|
2 weeks
|
|
Contrast Sensitivity
Time Frame: 2 weeks
|
Measurement of contrast sensitivity
|
2 weeks
|
|
Subjective Responses
Time Frame: 2 weeks
|
Assessment of subject responses related to wear time of spectacles
|
2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Joe Rappon, OD, MS, SightGlass Vision
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- P/639/18/SG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.